Status:
COMPLETED
Impact of Cigar Flavor in Dual Users
Lead Sponsor:
UConn Health
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
21-34 years
Phase:
NA
Brief Summary
The purpose of this study is to understand addiction to filtered cigars (FCs) compared to cigarettes in young adults, ages 21-34, who smoke both cigarettes and cigars. We are also looking to see if fl...
Detailed Description
The purpose of this remote study is to understand addiction to filtered cigars (FCs) compared to cigarettes in young adults, ages 21-34, who are dual users of cigarettes and cigars, if flavor, such as...
Eligibility Criteria
Inclusion
- Current regular dual uses of filtered cigars and cigarillos (FCs) and cigarettes defined as; (a) report smoking cigarettes at least weekly in the past 30 days, (b) report smoking unaltered FC (without marijuana) at least weekly in the past 30 days; and (c)report cigarette and cigar use at their current rate (or more frequently) for ≥ 3 months.
- Able to read, speak, and understand English
- Age 21-34 years
- Stable residence (does not intend to move during the study period)
- Not intending to quit smoking during the study period
- Has a smart phone with a data plan (this study is being done remotely)
- Saliva cotinine level \>30 ng/mL
Exclusion
- Self-reported current pregnancy, currently trying to become pregnant, or breast-feeding
- Current use of nicotine replacement products or cessation products (e.g., bupropion) or plans to use in the next 3 weeks for the purposes of cessation.
- Diagnosed with or being treated for COPD, emphysema, and/or uncontrolled asthma as determined by research screening.
- Currently taking anti-hypertensive medications
- Currently has pneumonia, bronchitis, or COVID symptoms that has not yet resolved, or was hospitalized or visited the ER in the past 4 weeks for a respiratory-related illness that has not yet resolved (can be re-screened once resolved)
- Resident of Alaska, Hawaii, or Massachusetts
Key Trial Info
Start Date :
June 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2024
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT04487470
Start Date
June 24 2020
End Date
November 30 2024
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UConn Health
Farmington, Connecticut, United States, 06030